Here, we described down-regulation of miR-181a-3p in SDS patients, suggesting its involvement in regulation of the pro-inflammatory and leukemogenic cellular programs downstream from lost SBDS expression. The gene discussed is SBDS; the disease is Shwachman-Diamond syndrome.